<DOC>
	<DOCNO>NCT01343823</DOCNO>
	<brief_summary>A double-blind , randomize , control trial compare safety effectiveness conventional therapy ecallantide conventional therapy placebo .</brief_summary>
	<brief_title>Evaluation Ecallantide Treatment Angiotensin Converting Enzyme ( ACE ) Inhibitor Induced Angioedema</brief_title>
	<detailed_description />
	<mesh_term>Angioedema</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<criteria>Males females 18 year age old Must currently ACE inhibitor therapy receive dose within 36 hour Presenting ACEIA head/neck region within 12 hour onset All female must negative urine pregnancy test prior administration study drug . Those total hysterectomy , bilateral oophorectomy two year postmenopausal require pregnancy test . Hypersensitivity ecallantide Pregnancy breast feeding Patients angioedema concurrently ACE inhibitor Patients exhibit urticaria Patients intubated tracheostomy related current episode angioedema Opinion investigator patient would good candidate Participation another investigational study within 30 day prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>